The Column Group Announces $1.23B Two New Funds

July 22, 2022Client News

Gunderson Dettmer represented client The Column Group (TCG) in the announcement of its two new funds, The Column Group V, a $615 million fund focused on early-stage investments and The Column Group Opportunity II, also a $615 million for later stage investments in TCG’s portfolio companies. The San Francisco-based venture capital firm seeks to partner with scientific founders, entrepreneurs, executives, and investment organizations with a shared vision for building the next generation of drug discovery and development companies.

The Gunderson team consisted of Andrew Thornborrow, Lily Kim and Amanda Chan.